Review: could Cladribine cause Peripheral Motor Neuropathy?


Peripheral motor neuropathy is reported only by a few people who take Cladribine. We study 818 people who have side effects while taking Cladribine from FDA and social media. Among them, 3 have Peripheral motor neuropathy. Find out below who they are, when they have Peripheral motor neuropathy and more.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Cladribine has active ingredients of cladribine. (latest outcomes from Cladribine 972 users)

Peripheral Motor Neuropathy

Peripheral motor neuropathy (muscles in the body become progressively weaker over months to years) has been reported by people with multiple myeloma, breast cancer, preventive health care, colon cancer, pain (latest reports from 942 Peripheral motor neuropathy patients).

On Oct, 09, 2016

818 people reported to have side effects when taking Cladribine.
Among them, 3 people (0.37%) have Peripheral Motor Neuropathy

Number of reports submitted per year:

Could Cladribine cause Peripheral motor neuropathy?

Gender of people who have Peripheral Motor Neuropathy when taking Cladribine *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Peripheral Motor Neuropathy when taking Cladribine *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 100 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Top conditions involved for these people *:

  • Chemotherapy (3 people, 100.00%)
  • Acute Lymphocytic Leukaemia (1 person, 33.33%)

Top co-used drugs for these people *:

  • Methotrexate (3 people, 100.00%)
  • Ifosfamide (3 people, 100.00%)
  • Dexamethasone (3 people, 100.00%)
  • Cytarabine (3 people, 100.00%)
  • Atriance (3 people, 100.00%)

Top other side effects for these people *:

  • Peripheral Sensory Neuropathy (3 people, 100.00%)
  • Paraplegia (3 people, 100.00%)
  • Paraesthesia (3 people, 100.00%)
  • Neurotoxicity (3 people, 100.00%)
  • Myelopathy (3 people, 100.00%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Peripheral motor neuropathy when taking Cladribine?

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.